Abstract | PURPOSE: DESIGN: Prospective nonrandomized case series and clinical laboratory investigation. METHODS: Ninety-six consecutive patients presenting with ocular inflammation between January and October 2007 were tested using QuantiFERON-TB Gold. Positive patients received a 6-month anti- tuberculosis treatment. Patient follow-up ranged from 12 months to 24 months. Treatment was considered effective at the end of follow-up, in cases of no or a 2-point decrease of ocular inflammation (SUN criteria) and systemic corticosteroids stopped or tapered to 10 mg/day. RESULTS: Mean age was 51 ± 17 years. Types of ocular inflammation included scleritis (n = 7), panuveitis (n = 34), and posterior (n = 15), intermediate (n = 14), and anterior uveitis (n = 15). QuantiFERON-TB Gold was positive in 42 cases (44%), negative in 51 cases (53%), and undetermined in 3 cases (3%). Among positive QuantiFERON-TB Gold patients, 25 received a full anti- tuberculosis treatment, which was effective in 15 cases (60%). Associated systemic steroids were given to 6 patients and tapered to 10 mg/day or less in all cases. Median QuantiFERON-TB Gold value was significantly higher in the group with a successful therapeutic response (7.67 IU/mL [0.46 to 33.37]) compared to the group with treatment failure (1.22 IU/mL [0.61 to 4.4]), P = .026. CONCLUSION: Results of anti- tuberculosis treatment were encouraging in QuantiFERON-TB Gold-positive ocular inflammation, especially with values over 2 IU/mL in our study, suggesting that a higher cut-off value than that given by the manufacturer should be considered to better identify ocular inflammation that can benefit from full anti- tuberculosis treatment.
|
Authors | Raquel Gineys, Bahram Bodaghi, Ghislaine Carcelain, Nathalie Cassoux, Le Thi Huong Boutin, Zahir Amoura, Phuc Lehoang, Salim Trad |
Journal | American journal of ophthalmology
(Am J Ophthalmol)
Vol. 152
Issue 3
Pg. 433-440.e1
(Sep 2011)
ISSN: 1879-1891 [Electronic] United States |
PMID | 21652022
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Antitubercular Agents
- Glucocorticoids
- Reagent Kits, Diagnostic
- Interferon-gamma
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antitubercular Agents
(therapeutic use)
- Diagnostic Techniques, Ophthalmological
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Interferon-gamma
(blood)
- Male
- Middle Aged
- Prospective Studies
- Reagent Kits, Diagnostic
- Reproducibility of Results
- Scleritis
(blood, diagnosis, drug therapy)
- Sensitivity and Specificity
- Tuberculin Test
- Tuberculosis, Ocular
(blood, diagnosis, drug therapy)
- Uveitis
(blood, diagnosis, drug therapy)
- Young Adult
|